European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)

NCT06495177 | Recruiting

• 1 other identifier: EAVI
• Study Type: observational
• Target: 8,000
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this observational study is to provide a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary heart disease (CHD), individuals at high cardiovascular disease risk and all those with hypertension, dyslipidaemia (including familial hypercholesterolaemia), diabetes and dysglycaemia and chronic kidney disease (CKD) and determine whether the European guidelines on cardiovascular disease prevention, hypertension, lipids, diabetes and chronic kidney disease are being followed.

Conditions

Coronary Disease; Acute Coronary Syndrome; Unstable Angina; ST Elevation Myocardial Infarction; Non-ST Elevation Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

• Proportions of hospital coronary patients and high risk individuals in primary care achieving European lifestyle, risk factors and therapeutic targets for cardiovascular disease prevention

  The management of risk in terms of lifestyle intervention and the use of drug therapies will be evaluated in relation to the lifestyle and therapeutic goals defined in the national and European guidelines on cardiovascular disease prevention.

  30 months

Study Arms (2)

Hospital Arm

Patients presenting with coronary heart disease

Primary Care Arm

People at high risk of cardiovascular disease

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study population is all consenting adult patients presenting with high risk of cardiovascular diseases identified by general practices medical note and all consenting adult patients presenting with coronary disease seen in clinic.

You may qualify if:

• Patients having signed an informed Consent
• Patients aged from 18 years old at the time of identification
• At least six and at most 24 months elapsed between the index event (the recruiting diagnostic or treatment criteria below) and the date of interview
• Patients meeting the recruiting diagnostic or treatment criteria:
• Coronary patients: Acute coronary events (acute coronary syndrome {STEMI or NSTEMI}, unstable angina) or an emergency or elective revascularisation for coronary artery disease (CABG, PCI)
• High cardiovascular disease (CVD) risk patients: patients free of CVD, who have been prescribed one or more of the following treatments: blood pressure and/or lipid-lowering and/or glucose lowering (diet and/or hypoglycaemic agents and/or insulin)

You may not qualify if:

• Patients living outside defined geographical areas
• Patients admitted to hospital from outside the geographical area or under the care of cardiologists in hospitals that do not participate in EUROASPIRE VI

Sponsors & Collaborators

• European Society of Cardiology: lead
• National Institute for Prevention and Cardiovascular Health, Ireland: collaborator

Study Sites (1)

Istanbul University, Cerrahpaşa Cardiology Institute

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Coronary Disease; Acute Coronary Syndrome; Angina, Unstable; ST Elevation Myocardial Infarction; Non-ST Elevated Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Angina Pectoris; Chest Pain; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Myocardial Infarction; Infarction; Ischemia; Pathologic Processes; Necrosis

Study Officials

• Pr David A Wood, MB ChB MSc

  National Institute for Prevention and Cardiovascular Health

  STUDY CHAIR

• Pr John William McEvoy, MB BCh BAO MEd MHS PhD

  National Institute for Prevention and Cardiovascular Health

  STUDY CHAIR

Central Study Contacts

Emilie Soriano

CONTACT

+33489872018; registries@escardio.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: NETWORK
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 2, 2024
• First Posted: July 10, 2024
• Study Start: June 7, 2024
• Primary Completion: August 1, 2025
• Study Completion (Estimated): December 1, 2029
• Last Updated: July 10, 2024

Record last verified: 2024-07

Locations

TU (1)